Cargando…
Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist’s Perspective
Biomarker testing has become standard of care for patients diagnosed with non-small cell lung carcinoma (NSCLC). Although, it can be successfully performed in circulating tumor cells, at present, the vast majority of investigations are carried out using direct tumor sampling, either through aspirati...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099940/ https://www.ncbi.nlm.nih.gov/pubmed/25077070 http://dx.doi.org/10.3389/fonc.2014.00182 |